| 
Citations
 | 
   web
Deacon, R. M. J., Hurley, M. J., Rebolledo, C. M., Snape, M., Altimiras, F. J., Farias, L., et al. (2017). Nrf2: a novel therapeutic target in fragile X syndrome is modulated by NNZ2566. Genes Brain Behav., 16(7), 1–10.
toggle visibility